Northwestern Mutual Investment Management Company’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.4M | Buy |
182,734
+805
| +0.4% | +$21.1K | 0.05% | 117 |
|
|
2026
Q1 | $5.11M | Buy |
181,929
+260
| +0.1% | +$6.92K | 0.08% | 79 |
|
|
2025
Q4 | $4.52M | Buy |
181,669
+460
| +0.3% | +$11.6K | 0.05% | 98 |
|
|
2025
Q3 | $4.62M | Sell |
181,209
-160
| -0.1% | -$3.95K | 0.07% | 88 |
|
|
2025
Q2 | $4.4M | Buy |
181,369
+1,130
| +0.6% | +$26.4K | 0.07% | 85 |
|
|
2025
Q1 | $4.57M | Buy |
180,239
+307
| +0.2% | +$8.03K | 0.07% | 71 |
|
|
2024
Q4 | $4.77M | Buy |
179,932
+333
| +0.2% | +$9.03K | 0.11% | 68 |
|
|
2024
Q3 | $5.2M | Sell |
179,599
-734
| -0.4% | -$21.4K | 0.12% | 64 |
|
|
2024
Q2 | $5.05M | Buy |
180,333
+1,163
| +0.6% | +$32K | 0.13% | 62 |
|
|
2024
Q1 | $4.97M | Buy |
179,170
+446
| +0.2% | +$12.4K | 0.13% | 62 |
|
|
2023
Q4 | $5.15M | Buy |
178,724
+517
| +0.3% | +$15.6K | 0.13% | 53 |
|
|
2023
Q3 | $5.91M | Buy |
178,207
+133
| +0.1% | +$4.7K | 0.16% | 42 |
|
|
2023
Q2 | $6.53M | Buy |
178,074
+1,625
| +0.9% | +$63.3K | 0.17% | 39 |
|
|
2023
Q1 | $7.2M | Buy |
176,449
+516
| +0.3% | +$22.3K | 0.18% | 33 |
|
|
2022
Q4 | $9.01M | Sell |
175,933
-32,520
| -16% | -$1.56M | 0.23% | 27 |
|
|
2022
Q3 | $9.12M | Sell |
208,453
-15,799
| -7% | -$768K | 0.23% | 27 |
|
|
2022
Q2 | $11.8M | Buy |
224,252
+979
| +0.4% | +$49.9K | 0.27% | 26 |
|
|
2022
Q1 | $11.6M | Sell |
223,273
-29,241
| -12% | -$1.52M | 0.26% | 35 |
|
|
2021
Q4 | $14.9M | Sell |
252,514
-2,132
| -0.8% | -$106K | 0.29% | 30 |
|
|
2021
Q3 | $11M | Buy |
254,646
+442
| +0.2% | +$19.6K | 0.22% | 43 |
|
|
2021
Q2 | $9.96M | Buy |
254,204
+1,349
| +0.5% | +$52.5K | 0.17% | 45 |
|
|
2021
Q1 | $9.16M | Sell |
252,855
-52,181
| -17% | -$1.85M | 0.16% | 46 |
|
|
2020
Q4 | $11.2M | Sell |
305,036
-16,594
| -5% | -$609K | 0.15% | 45 |
|
|
2020
Q3 | $9.98M | Hold |
321,630
| – | – | 0.14% | 45 |
|
|
2020
Q2 | $9.98M | Sell |
321,630
-251,180
| -44% | -$8.53M | 0.14% | 44 |
|
|
2020
Q1 | $17.7M | Buy |
572,810
+346,228
| +153% | +$11.8M | 0.27% | 32 |
|
|
2019
Q4 | $8.42M | Buy |
226,582
+4,578
| +2% | +$163K | 0.15% | 55 |
|
|
2019
Q3 | $7.57M | Buy |
222,004
+50
| +0% | +$1.82K | 0.17% | 60 |
|
|
2019
Q2 | $9.12M | Sell |
221,954
-667,230
| -75% | -$26.5M | 0.21% | 46 |
|
|
2019
Q1 | $35.8M | Sell |
889,184
-32,364
| -4% | -$1.3M | 0.65% | 36 |
|
|
2018
Q4 | $38.2M | Sell |
921,548
-159,662
| -15% | -$6.63M | 0.64% | 28 |
|
|
2018
Q3 | $45.2M | Sell |
1,081,210
-99,446
| -8% | -$3.83M | 0.69% | 28 |
|
|
2018
Q2 | $40.6M | Buy |
1,180,656
+38,589
| +3% | +$1.32M | 0.61% | 32 |
|
|
2018
Q1 | $38.5M | Sell |
1,142,067
-277,012
| -20% | -$9.52M | 0.64% | 25 |
|
|
2017
Q4 | $48.8M | Buy |
1,419,079
+8,836
| +0.6% | +$301K | 0.81% | 24 |
|
|
2017
Q3 | $47.8M | Sell |
1,410,243
-33,172
| -2% | -$1.07M | 0.78% | 23 |
|
|
2017
Q2 | $46M | Buy |
1,443,415
+175,320
| +14% | +$5.53M | 0.78% | 21 |
|
|
2017
Q1 | $41.2M | Buy |
1,268,095
+533,646
| +73% | +$16.8M | 0.73% | 22 |
|
|
2016
Q4 | $22.6M | Buy |
734,449
+101,954
| +16% | +$3.11M | 0.45% | 26 |
|
|
2016
Q3 | $20.3M | Buy |
632,495
+388,619
| +159% | +$13M | 0.43% | 24 |
|
|
2016
Q2 | $8.15M | Buy |
243,876
+468
| +0.2% | +$14.9K | 0.17% | 80 |
|
|
2016
Q1 | $6.84M | Sell |
243,408
-3,762
| -2% | -$107K | 0.15% | 100 |
|
|
2015
Q4 | $7.57M | Buy |
247,170
+6,963
| +3% | +$219K | 0.16% | 104 |
|
|
2015
Q3 | $7.16M | Buy |
240,207
+1,284
| +0.5% | +$41.2K | 0.15% | 101 |
|
|
2015
Q2 | $7.6M | Buy |
238,923
+1,853
| +0.8% | +$60.4K | 0.15% | 110 |
|
|
2015
Q1 | $7.83M | Buy |
+237,070
| New | +$7.54M | 0.16% | 113 |
|
Other funds holding PFE
Northwestern Mutual Investment Management Company's PFE Position: Q2 2026 in Review
Northwestern Mutual Investment Management Company increased its Pfizer (PFE) stake by 0.44% in Q2 2026, buying an estimated $21.1K and bringing the position to 182,734 shares worth $4.4M. The position accounts for 0.05% of the portfolio, ranked #117.
Northwestern Mutual Investment Management Company first reported a position in PFE in Q1 2015 and has held it in 46 quarters since. The position peaked at $48.8M in Q4 2017. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Northwestern Mutual Investment Management Company held 182,734 shares of Pfizer worth $4.4M as of Q2 2026.
- Northwestern Mutual Investment Management Company bought 805 Pfizer shares in Q2 2026, an estimated $21.1K.
- Pfizer made up 0.05% of Northwestern Mutual Investment Management Company's portfolio in Q2 2026, its #117 holding.
- Northwestern Mutual Investment Management Company first reported a position in Pfizer in Q1 2015 and has held it in 46 quarters since.
- Northwestern Mutual Investment Management Company's Pfizer position peaked at $48.8M in Q4 2017.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Northwestern Mutual Investment Management Company's 13F filing for Q2 2026, filed 12 Aug 2026.